Tuberculosis (TB) is the main reason for preventable loss of life in HIV-positive sufferers, and but typically stays undiagnosed and untreated. Chest x-ray is usually used to help in prognosis, but this presents further challenges as a result of atypical radiographic presentation and radiologist shortages in areas the place co-infection is most typical.
We developed a deep studying algorithm to diagnose TB utilizing scientific data and chest x-ray photographs from 677 HIV-positive sufferers with suspected TB from two hospitals in South Africa.
We then sought to find out whether or not the algorithm might help clinicians within the prognosis of TB in HIV-positive sufferers as a web-based diagnostic assistant.
Use of the algorithm resulted in a modest however statistically important enchancment in clinician accuracy (p = 0.002), growing the imply clinician accuracy from 0.60 (95% CI 0.57, 0.63) with out help to 0.65 (95% CI 0.60, 0.70) with help.
Nonetheless, the accuracy of assisted clinicians was considerably decrease (p < 0.001) than that of the stand-alone algorithm, which had an accuracy of 0.79 (95% CI 0.77, 0.82) on the identical unseen check instances.
These outcomes counsel that deep studying help might enhance clinician accuracy in TB prognosis utilizing chest x-rays, which might be worthwhile in settings with a excessive burden of HIV/TB co-infection. Furthermore, the excessive accuracy of the stand-alone algorithm suggests a possible worth significantly in settings with a shortage of radiological experience.

Tuberculosis Screening in Silica-Uncovered Staff : Creating a Software for Well being Care Suppliers

Each the Occupational Security and Well being Administration and Washington State require security and well being protections for staff uncovered to respirable crystalline silica, together with tuberculosis (TB) screening as a part of occupational medical surveillance.
We describe the creation of a TB screening device for silica-exposed staff receiving regulated medical surveillance examinations in Washington State. The device offers related scientific suggestions to help well being care suppliers and public well being practitioners who select to make use of the device when performing such examinations.
A cross-disciplinary group on the Washington State Division of Labor and Industries created the TB screening device to assist well being care suppliers establish silica-exposed staff who ought to obtain a complete analysis for energetic TB illness and staff who ought to or should obtain testing for latent TB an infection.
The Washington State Grownup Tuberculosis Screening Software for Staff Uncovered to Respirable Crystalline Silica advantages occupational and respiratory clinicians and public well being practitioners by aiding each the individual- and population-level supply of occupational well being and TB screening companies to silica-exposed staff receiving required medical surveillance examinations.

Using thalidomide to deal with kids with tuberculosis meningitis: A assessment

A lot of the morbidity and mortality attributable to tuberculous meningitis (TBM) is mediated by a dysregulated immune response. Efficient host-directed remedy is due to this fact important to enhance survival and scientific outcomes.
At the moment just one host-directed remedy (HDT), corticosteroids, is confirmed to enhance mortality. Nonetheless, there isn’t a proof that corticosteroids scale back morbidity and the mechanism of motion for mortality discount is unsure.
Additional, it has no confirmed profit in HIV co-infected people. One promising host-directed remedy strategy is to limit the immunopathology arising from tumour necrosis issue (TNF)-α extra is by way of TNF-α inhibitors. There are accumulating knowledge on the function of thalidomide, anti-TNF-α monoclonal antibodies (infliximab, adalimumab) and the soluble TNF-α receptor (etanercept) in TBM remedy.
Thalidomide was developed practically seventy years in the past and has been a extremely controversial drug. Delivery defects and poisonous hostile results have restricted its use however an improved understanding of its immunological mechanism of motion counsel that it could have an important function in regulating the damaging host response seen in inflammatory situations similar to TBM.
Observational research at our establishment discovered low dosage adjunctive thalidomide secure in treating tuberculous mass lesions and blindness associated to optochiasmatic arachnoiditis, with good scientific and radiological response.
On this assessment, we focus on attainable mechanisms of motion for thalidomide, primarily based on our clinico-radiologic expertise and autopsy histopathological work. We additionally suggest a rationale for its use within the remedy of sure TBM-related issues.

Co-existence of pulmonary tuberculosis with sarcoidosis

Tuberculosis (TB) and sarcoidosis are multisystem, continual granulomatous ailments. Though characterised by comparable scientific manifestations, these illness entities differ considerably in etiologies and administration.
Sarcoidosis is an immunological dysfunction of unknown etiology, characterised by the presence of noncaseating granulomas within the tissues concerned.
TB is the infectious illness attributable to Mycobacterium tuberculosis, characterised by granulomas with caseous necrosis. It’s uncommon to have each the ailments concomitantly. We current the case of a 38-year-old male with microbiological affirmation of coexistent pulmonary TB and sarcoidosis.

Concomitant disseminated tuberculosis and lepromatous leprosy in a beforehand wholesome male

Tuberculosis (TB) and leprosy are two continual mycobacterial infections attributable to intracellular Gram-positive cardio acid-fast bacilli. Each have extremely variable displays relying on immunological milieu of the host and account for important illness morbidity.
The burden of those age-old infections of humanity nonetheless stays excessive in India. Whatever the similar geographical endemicity of the 2, coinfections are sparsely reported. Certainly, research have revealed an antagonism between them.
Of the few coinfections reported up to now, majority had been recognized over a temporal sequence, with one occurring after the opposite, and most of those had been localized types of TB related to leprosy.
Solely a single case of disseminated TB and lepromatous leprosy has been reported within the medical literature until date. Right here, we report one other uncommon case of disseminated TB and lepromatous leprosy that in the end proved deadly for the affected person. The prognosis of the 2 ailments was made concurrently which is once more rare within the reported literature.

Reproducibility of the Ribosomal RNA Synthesis Ratio in Sputum and Affiliation with Markers of Mycobacterium tuberculosis Burden

There’s a important want for improved pharmacodynamic markers to be used in human tuberculosis (TB) drug trials. Pharmacodynamic monitoring in TB has conventionally used tradition or molecular strategies to enumerate the burden of Mycobacterium tuberculosis organisms in sputum.
A just lately proposed assay referred to as the rRNA synthesis (RS) ratio measures a essentially novel property, how medication affect ongoing bacterial rRNA synthesis. Right here, we evaluated RS ratio as a possible pharmacodynamic monitoring device by testing pretreatment sputa from 38 Ugandan adults with drug-susceptible pulmonary TB.
We quantified the RS ratio in paired pretreatment sputa and evaluated the connection between the RS ratio and microbiologic and molecular markers of M. tuberculosis burden. We discovered that the RS ratio was extremely repeatable and reproducible in sputum samples.
The RS ratio was unbiased of M. tuberculosis burden, confirming that it measures a definite new property. In distinction, markers of M. tuberculosis burden had been strongly related to one another.
These outcomes point out that the RS ratio is repeatable and reproducible and offers a definite kind of data from markers of M. tuberculosis burden.
IMPORTANCE This examine takes a serious subsequent step towards sensible software of a novel pharmacodynamic marker that we imagine can have transformative implications for tuberculosis.

Recombinant other DnaK Mycobacterium Tuberculosis Protein, Untagged, E.coli-10ug

QP11686-10ug 10ug
EUR 241.2

Mycobacterium tuberculosis 16kD (M. tuberculosis)

MBS6009340-1mg 1(mg
EUR 885

Mycobacterium tuberculosis 16kD (M. tuberculosis)

MBS6009340-5x1mg 5x1mg
EUR 3830

Mycobacterium tuberculosis 16kD (M. tuberculosis)

MBS6011625-1mg 1(mg
EUR 1295

Mycobacterium tuberculosis 16kD (M. tuberculosis)

MBS6011625-5x1mg 5x1mg
EUR 5675

MYCOBACTERIUM TUBERCULOSIS

GWB-FB7063 0.05 mg Ask for price

Mycobacterium tuberculosis

Oneq-VH201-OneqVH201100D Oneq-VH201-100D
EUR 515

Mycobacterium tuberculosis

Oneq-VH201-OneqVH201150D Oneq-VH201-150D
EUR 594

Mycobacterium tuberculosis

Oneq-VH201-OneqVH20150D Oneq-VH201-50D
EUR 413

Mycobacterium tuberculosis

PCR-VH201-PCRVH20148D PCR-VH201-48D
EUR 230

Mycobacterium tuberculosis

PCR-VH201-PCRVH20196D PCR-VH201-96D
EUR 312

Mycobacterium tuberculosis

MBS6507984-01mg 0.1mg
EUR 580

Mycobacterium tuberculosis

MBS6507984-5x01mg 5x0.1mg
EUR 2470

Mycobacterium tuberculosis

MBS324183-1mL 1mL
EUR 320

Mycobacterium tuberculosis

MBS324183-5x1mL 5x1mL
EUR 1355

Mycobacterium tuberculosis

MBS324184-1mL 1mL
EUR 335

Mycobacterium tuberculosis

MBS324184-5x1mL 5x1mL
EUR 1410

Mycobacterium tuberculosis

MBS324185-1mL 1mL
EUR 355

Mycobacterium tuberculosis

MBS324185-5x1mL 5x1mL
EUR 1500

Mycobacterium tuberculosis

MBS324186-1mL 1mL
EUR 335

Mycobacterium tuberculosis

MBS324186-5x1mL 5x1mL
EUR 1410

Mycobacterium tuberculosis

MBS373078-01mLConcentrate 0.1mL(Concentrate)
EUR 205

Mycobacterium tuberculosis

MBS373078-05mLConcentrate 0.5mL(Concentrate)
EUR 310

Mycobacterium tuberculosis

MBS373078-3mLRTU 3mL(RTU)
EUR 205

Mycobacterium tuberculosis

MBS373078-5ControlSlides 5ControlSlides
EUR 220

Mycobacterium tuberculosis

MBS373078-7mLRTU 7mL(RTU)
EUR 310

Mycobacterium tuberculosis

MBS328055-01mg 0.1mg
EUR 435

Mycobacterium tuberculosis

MBS328055-5x01mg 5x0.1mg
EUR 1865

Mycobacterium tuberculosis

MBS320211-01mg 0.1mg
EUR 355

Mycobacterium tuberculosis

MBS320211-5x01mg 5x0.1mg
EUR 1500

Mycobacterium tuberculosis

MBS320212-01mg 0.1mg
EUR 355

Mycobacterium tuberculosis

MBS320212-5x01mg 5x0.1mg
EUR 1500

Mycobacterium tuberculosis

MBS320213-01mg 0.1mg
EUR 355

Mycobacterium tuberculosis

MBS320213-5x01mg 5x0.1mg
EUR 1500

Mycobacterium tuberculosis

MBS320214-01mg 0.1mg
EUR 355

Mycobacterium tuberculosis

MBS320214-5x01mg 5x0.1mg
EUR 1500

Mycobacterium tuberculosis

MBS320334-01mg 0.1mg
EUR 355

Mycobacterium tuberculosis

MBS320334-5x01mg 5x0.1mg
EUR 1500

Mycobacterium tuberculosis

MBS320336-01mg 0.1mg
EUR 355

Mycobacterium tuberculosis

MBS320336-5x01mg 5x0.1mg
EUR 1500

Mycobacterium tuberculosis (M. tuberculosis) Antibody

abx415707-1ml 1 ml
EUR 727.2

Mycobacterium tuberculosis (M. tuberculosis) Antibody

abx415707-200l 200 µl
EUR 537.5

Mycobacterium tuberculosis 16kD (M. tuberculosis) (PE)

MBS6129466-01mL 0.1(mL
EUR 1240

Mycobacterium tuberculosis 16kD (M. tuberculosis) (PE)

MBS6129466-5x01mL 5x0.1mL
EUR 5430

Mycobacterium tuberculosis 16kD (M. tuberculosis) (PE)

MBS6129467-01mL 0.1(mL
EUR 1095

Mycobacterium tuberculosis 16kD (M. tuberculosis) (PE)

MBS6129467-5x01mL 5x0.1mL
EUR 4775

Mycobacterium tuberculosis 16kD (M. tuberculosis) (AP)

MBS6126370-01mL 0.1(mL
EUR 1240

Mycobacterium tuberculosis 16kD (M. tuberculosis) (AP)

MBS6126370-5x01mL 5x0.1mL
EUR 5430

Mycobacterium tuberculosis 16kD (M. tuberculosis) (AP)

MBS6126371-01mL 0.1(mL
EUR 1095

Mycobacterium tuberculosis 16kD (M. tuberculosis) (AP)

MBS6126371-5x01mL 5x0.1mL
EUR 4775

Mycobacterium tuberculosis 16kD (M. tuberculosis) (HRP)

MBS6128846-01mL 0.1(mL
EUR 1240

Mycobacterium tuberculosis 16kD (M. tuberculosis) (HRP)

MBS6128846-5x01mL 5x0.1mL
EUR 5430

Mycobacterium tuberculosis 16kD (M. tuberculosis) (HRP)

MBS6128847-01mL 0.1(mL
EUR 1095

Mycobacterium tuberculosis 16kD (M. tuberculosis) (HRP)

MBS6128847-5x01mL 5x0.1mL
EUR 4775

Mycobacterium tuberculosis 16kD (M. tuberculosis) (APC)

MBS6126990-01mL 0.1(mL
EUR 1240

Mycobacterium tuberculosis 16kD (M. tuberculosis) (APC)

MBS6126990-5x01mL 5x0.1mL
EUR 5430

Mycobacterium tuberculosis 16kD (M. tuberculosis) (APC)

MBS6126991-01mL 0.1(mL
EUR 1095

Mycobacterium tuberculosis 16kD (M. tuberculosis) (APC)

MBS6126991-5x01mL 5x0.1mL
EUR 4775

Mycobacterium tuberculosis 16kD (M. tuberculosis) (FITC)

MBS6128225-01mL 0.1(mL
EUR 1240

Mycobacterium tuberculosis 16kD (M. tuberculosis) (FITC)

MBS6128225-5x01mL 5x0.1mL
EUR 5430

Mycobacterium tuberculosis 16kD (M. tuberculosis) (FITC)

MBS6128226-01mL 0.1(mL
EUR 1095

Mycobacterium tuberculosis 16kD (M. tuberculosis) (FITC)

MBS6128226-5x01mL 5x0.1mL
EUR 4775

Mycobacterium tuberculosis 16kD (M. tuberculosis) (Biotin)

MBS6127611-01mL 0.1(mL
EUR 1240

Mycobacterium tuberculosis 16kD (M. tuberculosis) (Biotin)

MBS6127611-5x01mL 5x0.1mL
EUR 5430

Mycobacterium tuberculosis 16kD (M. tuberculosis) (Biotin)

MBS6127612-01mL 0.1(mL
EUR 1095

Mycobacterium tuberculosis 16kD (M. tuberculosis) (Biotin)

MBS6127612-5x01mL 5x0.1mL
EUR 4775

Recombinant purified Mycobacterium Tuberculosis Heat Shock Protein 70 (hsp70/Dnak/ML2496)

RP-628 10 ug
EUR 343.2

Mycobacterium tuberculosis (AP)

MBS6450376-01mL 0.1mL
EUR 700

Mycobacterium tuberculosis (AP)

MBS6450376-5x01mL 5x0.1mL
EUR 2995

Mycobacterium tuberculosis (PE)

MBS6450386-01mL 0.1mL
EUR 700

Mycobacterium tuberculosis (PE)

MBS6450386-5x01mL 5x0.1mL
EUR 2995

Mycobacterium tuberculosis (APC)

MBS6450377-01mL 0.1mL
EUR 700

Mycobacterium tuberculosis (APC)

MBS6450377-5x01mL 5x0.1mL
EUR 2995

Mycobacterium tuberculosis (HRP)

MBS6450380-01mL 0.1mL
EUR 700

Mycobacterium tuberculosis (HRP)

MBS6450380-5x01mL 5x0.1mL
EUR 2995

Mycobacterium tuberculosis Genomic DNA

MBT107-250R 1 unit
EUR 119.62
Description: Mycobacterium tuberculosis Genomic DNA

Mycobacterium tuberculosis, 38kD

MBS609237-1mg 1mg
EUR 855

Mycobacterium tuberculosis, 38kD

MBS609237-5x1mg 5x1mg
EUR 3700

Mycobacterium tuberculosis, 38kD

MBS609285-1mg 1mg
EUR 925

Mycobacterium tuberculosis, 38kD

MBS609285-5x1mg 5x1mg
EUR 4015

Mycobacterium tuberculosis (FITC)

MBS6450379-01mL 0.1mL
EUR 700

Mycobacterium tuberculosis (FITC)

MBS6450379-5x01mL 5x0.1mL
EUR 2995

Mycobacterium tuberculosis, HSPX

MBS632079-1mL 1mL
EUR 555

Mycobacterium tuberculosis, HSPX

MBS632079-5x1mL 5x1mL
EUR 2355

Mycobacterium tuberculosis, 38kD

MBS631535-1mg 1mg
EUR 885

Mycobacterium tuberculosis, 38kD

MBS631535-5x1mg 5x1mg
EUR 3830

Mycobacterium tuberculosis, HSPX

MBS633358-1mL 1mL
EUR 555

Mycobacterium tuberculosis, HSPX

MBS633358-5x1mL 5x1mL
EUR 2355

Mycobacterium tuberculosis 38kDa

GWB-67DB4A 5 mg Ask for price

Mycobacterium tuberculosis 16kDa

GWB-7F0CCF 5 mg Ask for price

Mycobacterium tuberculosis CFP10

MBS601269-01mg 0.1mg
EUR 325

Mycobacterium tuberculosis CFP10

MBS601269-1mg 1mg
EUR 1080

Mycobacterium tuberculosis CFP10

MBS601269-5x1mg 5x1mg
EUR 4700

Mycobacterium tuberculosis ESAT6

MBS6506783-01mg 0.1mg
EUR 760

Mycobacterium tuberculosis ESAT6

MBS6506783-5x01mg 5x0.1mg
EUR 3265

Mycobacterium tuberculosis CFP10

MBS602176-1mg 1mg
EUR 1080

Mycobacterium tuberculosis CFP10

MBS602176-5x1mg 5x1mg
EUR 4700

Mycobacterium tuberculosis (Biotin)

MBS6450378-01mL 0.1mL
EUR 700

Mycobacterium tuberculosis (Biotin)

MBS6450378-5x01mL 5x0.1mL
EUR 2995

Mycobacterium tuberculosis Antibody

abx022066-1mg 1 mg
EUR 1220.4

Mycobacterium tuberculosis Antibody

abx022067-1mg 1 mg
EUR 1296

Mycobacterium tuberculosis Antibody

abx022073-1mg 1 mg
EUR 1296

Mycobacterium tuberculosis Antibody

abx022087-1mg 1 mg
EUR 994.8

Mycobacterium tuberculosis Antibody

abx022088-1mg 1 mg
EUR 994.8

Mycobacterium tuberculosis Antibody

abx022089-1mg 1 mg
EUR 944.4

Mycobacterium tuberculosis Antibody

abx022090-1mg 1 mg
EUR 944.4

Mycobacterium tuberculosis Antibody

abx023092-1ml 1 ml
EUR 718.8

Mycobacterium tuberculosis antibody

20-MR50 1 mg
EUR 110
Description: Rabbit polyclonal Mycobacterium tuberculosis antibody

Mycobacterium tuberculosis Antibody

GWB-37A518 0.5 ml Ask for price

Mycobacterium tuberculosis Antibody

GWB-52959A 1 ml Ask for price

Mycobacterium tuberculosis Antibody

GWB-613CF2 1 ml Ask for price

Mycobacterium tuberculosis, Antibody

GWB-1A49B9 0.1 mg Purified Ask for price

Mycobacterium tuberculosis Antibody

GWB-AE5BA3 1 ml Ask for price

Mycobacterium Tuberculosis Antibody

GWB-EF714E 1 ml Ask for price

Mycobacterium tuberculosis Antibody

GWB-CAE926 1 ml Ask for price

Mycobacterium tuberculosis Antibody

abx022066-400l 400 µl Ask for price

Mycobacterium tuberculosis Antibody

abx022066-80l 80 µl
EUR 1200

Mycobacterium tuberculosis Antibody

abx022067-400l 400 µl Ask for price

Mycobacterium tuberculosis Antibody

abx022067-80l 80 µl
EUR 1287.5

Mycobacterium tuberculosis Antibody

abx022073-400l 400 µl Ask for price

Mycobacterium tuberculosis Antibody

abx022073-80l 80 µl
EUR 1287.5

Mycobacterium tuberculosis Antibody

abx023092-400l 400 µl Ask for price

Mycobacterium tuberculosis Antibody

abx023092-80l 80 µl
EUR 1012.5

Mycobacterium tuberculosis Antibody

MBS568506-05mL 0.5mL
EUR 305

Mycobacterium tuberculosis Antibody

MBS568506-5x05mL 5x0.5mL
EUR 1180

Mycobacterium tuberculosis antibody

MBS534825-1mg 1mg
EUR 240

Mycobacterium tuberculosis PCR kit

PCR-VH201-48D 50T
EUR 543.6

Mycobacterium tuberculosis PCR kit

PCR-VH201-96D 100T
EUR 686.4

Mycobacterium tuberculosis, 38kD (PE)

MBS6129472-01mL 0.1(mL
EUR 1135

Mycobacterium tuberculosis, 38kD (PE)

MBS6129472-5x01mL 5x0.1mL
EUR 4960

Mycobacterium tuberculosis, 38kD (PE)

MBS6129473-01mL 0.1(mL
EUR 1095

Mycobacterium tuberculosis, 38kD (PE)

MBS6129473-5x01mL 5x0.1mL
EUR 4775

Mycobacterium tuberculosis, 38kD (PE)

MBS6129474-01mL 0.1(mL
EUR 1070

Mycobacterium tuberculosis, 38kD (PE)

MBS6129474-5x01mL 5x0.1mL
EUR 4670

Mycobacterium tuberculosis, 38kD (AP)

MBS6126376-01mL 0.1(mL
EUR 1135

Mycobacterium tuberculosis, 38kD (AP)

MBS6126376-5x01mL 5x0.1mL
EUR 4960

Mycobacterium tuberculosis, 38kD (AP)

MBS6126377-01mL 0.1(mL
EUR 1095

Mycobacterium tuberculosis, 38kD (AP)

MBS6126377-5x01mL 5x0.1mL
EUR 4775

Mycobacterium tuberculosis, 38kD (AP)

MBS6126378-01mL 0.1(mL
EUR 1070

Mycobacterium tuberculosis, 38kD (AP)

MBS6126378-5x01mL 5x0.1mL
EUR 4670

Insta NX® Mycobacterium Tuberculosis DNA

MBIN019-12PR 1 unit
EUR 71.73
Description: Insta NX® Mycobacterium Tuberculosis DNA

Mycobacterium tuberculosis, 38kD (HRP)

MBS6128852-01mL 0.1(mL
EUR 1135

Mycobacterium tuberculosis, 38kD (HRP)

MBS6128852-5x01mL 5x0.1mL
EUR 4960

Mycobacterium tuberculosis, 38kD (HRP)

MBS6128853-01mL 0.1(mL
EUR 1095

Mycobacterium tuberculosis, 38kD (HRP)

MBS6128853-5x01mL 5x0.1mL
EUR 4775

Mycobacterium tuberculosis, 38kD (HRP)

MBS6128854-01mL 0.1(mL
EUR 1070

Mycobacterium tuberculosis, 38kD (HRP)

MBS6128854-5x01mL 5x0.1mL
EUR 4670

Mycobacterium tuberculosis CFP10 (PE)

MBS6129468-01mL 0.1(mL
EUR 1285

Mycobacterium tuberculosis CFP10 (PE)

MBS6129468-5x01mL 5x0.1mL
EUR 5640

Mycobacterium tuberculosis CFP10 (PE)

MBS6129469-01mL 0.1(mL
EUR 1285

Mycobacterium tuberculosis CFP10 (PE)

MBS6129469-5x01mL 5x0.1mL
EUR 5640

Mycobacterium tuberculosis, 38kD (APC)

MBS6126996-01mL 0.1(mL
EUR 1135

Mycobacterium tuberculosis, 38kD (APC)

MBS6126996-5x01mL 5x0.1mL
EUR 4960

Mycobacterium tuberculosis, 38kD (APC)

MBS6126997-01mL 0.1(mL
EUR 1095

Mycobacterium tuberculosis, 38kD (APC)

MBS6126997-5x01mL 5x0.1mL
EUR 4775

Mycobacterium tuberculosis, 38kD (APC)

MBS6126998-01mL 0.1(mL
EUR 1070

Mycobacterium tuberculosis, 38kD (APC)

MBS6126998-5x01mL 5x0.1mL
EUR 4670

Mycobacterium tuberculosis CFP10 (AP)

MBS6126372-01mL 0.1(mL
EUR 1285

Mycobacterium tuberculosis CFP10 (AP)

MBS6126372-5x01mL 5x0.1mL
EUR 5640

Mycobacterium tuberculosis CFP10 (AP)

MBS6126373-01mL 0.1(mL
EUR 1285

Mycobacterium tuberculosis CFP10 (AP)

MBS6126373-5x01mL 5x0.1mL
EUR 5640

Mycobacterium Tuberculosis-IN-2

HY-157431 Get quote Ask for price
Description: Mycobacterium Tuberculosis-IN-2 (Compound 29) is a bacterial inhibitor that effectively inhibits Mycobacterium Tuberculosis. Mycobacterium Tuberculosis-IN-2 can be used in tuberculosis research[1].

HiPurA® Mycobacterium Tuberculosis DNA P

MB545-20PR 1 unit
EUR 45.83
Description: HiPurA® Mycobacterium Tuberculosis DNA P

HiPurA® Mycobacterium Tuberculosis DNA P

MB545-250PR 1 unit
EUR 415.6
Description: HiPurA® Mycobacterium Tuberculosis DNA P

HiPurA® Mycobacterium Tuberculosis DNA P

MB545-50PR 1 unit
EUR 91.58
Description: HiPurA® Mycobacterium Tuberculosis DNA P

Mycobacterium tuberculosis IgA ELISA

GWB-20EB9D ELISA_Kits Ask for price

Mycobacterium tuberculosis IgM ELISA

GWB-784B40 ELISA_Kits Ask for price

Mycobacterium tuberculosis IgG ELISA

GWB-FFE4D4 ELISA_Kits Ask for price

Mycobacterium tuberculosis CFP10 (HRP)

MBS6128848-01mL 0.1(mL
EUR 1285

Mycobacterium tuberculosis CFP10 (HRP)

MBS6128848-5x01mL 5x0.1mL
EUR 5640

Mycobacterium tuberculosis CFP10 (HRP)

MBS6128849-01mL 0.1(mL
EUR 1285

Mycobacterium tuberculosis CFP10 (HRP)

MBS6128849-5x01mL 5x0.1mL
EUR 5640

Mycobacterium tuberculosis CFP10 (APC)

MBS6126992-01mL 0.1(mL
EUR 1285

Mycobacterium tuberculosis CFP10 (APC)

MBS6126992-5x01mL 5x0.1mL
EUR 5640

Mycobacterium tuberculosis CFP10 (APC)

MBS6126993-01mL 0.1(mL
EUR 1285

Mycobacterium tuberculosis CFP10 (APC)

MBS6126993-5x01mL 5x0.1mL
EUR 5640

Mycobacterium tuberculosis, 38kD (FITC)

MBS6128231-01mL 0.1(mL
EUR 1135

Mycobacterium tuberculosis, 38kD (FITC)

MBS6128231-5x01mL 5x0.1mL
EUR 4960

Mycobacterium tuberculosis, 38kD (FITC)

MBS6128232-01mL 0.1(mL
EUR 1095

Mycobacterium tuberculosis, 38kD (FITC)

MBS6128232-5x01mL 5x0.1mL
EUR 4775

Mycobacterium tuberculosis, 38kD (FITC)

MBS6128233-01mL 0.1(mL
EUR 1070

Mycobacterium tuberculosis, 38kD (FITC)

MBS6128233-5x01mL 5x0.1mL
EUR 4670

Mycobacterium tuberculosis CFP10 (FITC)

MBS6128227-01mL 0.1(mL
EUR 1285

Mycobacterium tuberculosis CFP10 (FITC)

MBS6128227-5x01mL 5x0.1mL
EUR 5640

Mycobacterium tuberculosis CFP10 (FITC)

MBS6128228-01mL 0.1(mL
EUR 1285

Mycobacterium tuberculosis CFP10 (FITC)

MBS6128228-5x01mL 5x0.1mL
EUR 5640

Mycobacterium tuberculosis (TB) Antibody

MBS569356-1mg 1mg
EUR 655

Mycobacterium tuberculosis (TB) Antibody

MBS569356-5x1mg 5x1mg
EUR 2760
This text follows our latest report in Nature Communications that an assay referred to as the rRNA synthesis (RS) ratio signifies the treatment-shortening of medication and regimens.
Distinct from conventional measures of bacterial burden, the RS ratio measures a essentially novel property, how medication affect ongoing bacterial rRNA synthesis.

LEAVE A REPLY

Please enter your comment!
Please enter your name here